# Screening for Amyloidosis Before Aortic Valve Elective Replacement

> **NCT04869631** · — · ACTIVE_NOT_RECRUITING · sponsor: **Charite University, Berlin, Germany** · enrollment: 1000 (actual)

## Conditions studied

- Amyloidosis
- Aortic Valve Stenosis

## Interventions

- **OTHER:** The outcome of an intervention is not evaluated, but aortic stenosis and additional amyloidosis are compared.

## Key facts

- **NCT ID:** NCT04869631
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04869631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04869631, "Screening for Amyloidosis Before Aortic Valve Elective Replacement". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04869631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
